Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 44 pages
Exam (elaborations)

NU 578 Advanced Pharmacology – Units 1–5 Exam Questions And Answers Plus Rationales | Qs & Ans 2026 | Instant Pdf Download

Document preview thumbnail
Preview 4 out of 44 pages

Master advanced pharmacology with this 100-question practice set for nurse practitioners (NU 578). Covers pharmacokinetics, pharmacodynamics, drug interactions, CYP enzymes, narrow-therapeutic-index drugs (warfarin, lithium, digoxin), adverse reactions, and evidence-based prescribing. Each answer includes detailed clinical rationales—ideal for NP certification and pharmacology course success.

Content preview

NU 578 Advanced Pharmacology – Units
1–5 Exam Questions And Answers Plus
Rationales | Qs & Ans 2026 | Instant Pdf
Download
1. A patient with hepatic cirrhosis has a decreased ability to
metabolize drugs. Which phase of pharmacokinetics is most directly

affected by liver disease?

A. Absorption

B. Distribution

C. Metabolism (biotransformation)

D. Excretion

Answer: C
Rationale: The liver is the primary site of drug metabolism (Phase I and

II reactions). Cirrhosis reduces metabolic capacity, leading to drug

accumulation.

2. A drug has a half-life of 4 hours. How long will it take for the

drug to reach steady state if administered at regular intervals?

A. 8 hours
B. 12 hours

C. 20 hours

D. 24 hours

,Answer: C

Rationale: Steady state is achieved after approximately 4–5 half-lives. 4

hours × 5 = 20 hours.

3. A nurse practitioner prescribes a medication that is a weak acid

with a pKa of 4.5. Where will this drug primarily be absorbed?

A. Stomach (pH 1.5–3.5)
B. Small intestine (pH 6–7)

C. Colon

D. Rectum

Answer: A

Rationale: Weak acids are nonionized (lipid-soluble) in acidic

environments (pH lower than pKa), favoring absorption in the stomach.

4. A patient taking warfarin is started on amiodarone. The INR
increases from 2.5 to 5.5. Which type of drug interaction is this?

A. Pharmacodynamic antagonism

B. Pharmacokinetic (metabolism inhibition)

C. Additive effect

D. Physiologic antagonism

Answer: B

Rationale: Amiodarone inhibits CYP2C9 and CYP1A2, reducing warfarin

metabolism, increasing INR and bleeding risk.

5. A patient with a genetic variant of CYP2D6 is a “poor

metabolizer.” Which medication would require a lower dose or

,alternative agent?

A. Lisinopril

B. Codeine (requires conversion to morphine via CYP2D6)
C. Metformin

D. Furosemide

Answer: B
Rationale: Codeine is a prodrug converted to morphine by CYP2D6.

Poor metabolizers have inadequate analgesia; ultrarapid metabolizers

risk toxicity.

6. A drug has a volume of distribution (Vd) of 500 L in a 70 kg adult.

Which interpretation is correct?

A. The drug is confined to the plasma

B. The drug is highly protein-bound
C. The drug is extensively distributed into tissues

D. The drug is excreted unchanged in urine

Answer: C

Rationale: High Vd (>42 L) indicates extensive tissue distribution, not

confined to plasma or extracellular fluid.

7. A patient develops urticaria, angioedema, and hypotension after

receiving IV penicillin. Which type of adverse drug reaction is this?

A. Type A (augmented)

B. Type B (bizarre/hypersensitivity) – Type I IgE-mediated

, C. Type C (chronic)

D. Type D (delayed)

Answer: B
Rationale: Type B reactions are idiosyncratic or allergic. Anaphylaxis is a

Type I IgE-mediated hypersensitivity (Type B).

8. Which statement best describes the therapeutic index (TI)?
A. TI = TD50/ED50; a high TI indicates a safe drug

B. TI = ED50/TD50; a low TI indicates a safe drug

C. TI = LD50/ED50; a narrow TI requires therapeutic drug monitoring

D. TI = ED50/LD50; a narrow TI is desirable

Answer: C

Rationale: Therapeutic index = LD50/ED50 (animal) or TD50/ED50

(human). Narrow TI drugs (e.g., digoxin, warfarin, lithium) require
monitoring.

9. A patient with myasthenia gravis is taking neostigmine. Which

effect is mediated by muscarinic receptors?

A. Increased skeletal muscle strength

B. Bradycardia and salivation

C. Tachycardia

D. Mydriasis

Answer: B

Rationale: Neostigmine (acetylcholinesterase inhibitor) increases

Document information

Uploaded on
June 8, 2026
Number of pages
44
Written in
2025/2026
Type
Exam (elaborations)
Contains
Questions & answers
$21.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Sold
229
Followers
28
Items
8069
Last sold
1 day ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions